Cargando…

Evaluation of microalbuminuria in obesity phenotypes

BACKGROUND: Obesity is a universal health issue of the present time. Nearly 2 billion people were estimated to be either overweight or obese in 2020, with nearly 3.4 million deaths worldwide. Proteinuria is now widely known to be a significant predictor of renal pathologies including end-stage renal...

Descripción completa

Detalles Bibliográficos
Autores principales: Alagh, Arzoo R., Shukla, Samarth, Acharya, Sourya, Vagha, Sunita, Dhingra, Loveleen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221229/
https://www.ncbi.nlm.nih.gov/pubmed/35754751
http://dx.doi.org/10.4103/jfcm.jfcm_57_22
_version_ 1784732569318719488
author Alagh, Arzoo R.
Shukla, Samarth
Acharya, Sourya
Vagha, Sunita
Dhingra, Loveleen
author_facet Alagh, Arzoo R.
Shukla, Samarth
Acharya, Sourya
Vagha, Sunita
Dhingra, Loveleen
author_sort Alagh, Arzoo R.
collection PubMed
description BACKGROUND: Obesity is a universal health issue of the present time. Nearly 2 billion people were estimated to be either overweight or obese in 2020, with nearly 3.4 million deaths worldwide. Proteinuria is now widely known to be a significant predictor of renal pathologies including end-stage renal disease. This study aimed to assess the relationship between the presence of microalbuminuria (MA) in obese individuals. MATERIALS AND METHODS: This cross-sectional study was conducted among patients attending the outpatient department of Jawaharlal Nehru Medical College and Acharya Vinoba Bhave Rural Hospital, Sawangi (Meghe), Wardha. From the subjects meeting the study criteria, selected 150 individuals with BMI ≥ 25 that formed the obese group. Obese individuals were further subdivided as metabolic healthy obese (MHO) and metabolic abnormal obese (MAO) based on metablic syndrome criteria. From the non-obese patients (BMI≤25), one age and gender matched control was selected for each obese subject. All subjects were tested for MA by dipstick method. Data was analyzed using SPSS and Chi-square test was performed to test for statistical significance. RESULTS: The study reflected the association of MA in the groups studied. The metabolic abnormal obese group was noted as having the highest percentage of positive cases (53.7%) of MA, followed by the MHO group (31.3%). A significant association of prevalence of MA was seen in MHO and MAO obese individuals (P < 0.001). MA was present in the urine samples of 26 (31.3%) obese subjects in the MHO group, 36 (53.7%) in the MAO group, and 8 (5.3%) in the control population. CONCLUSION: Both MHO and MAO subgroups of obese individuals showed higher proportion of MA indicating adverse renal function. Therefore, primary prophylactic measures such as health education and lifestyle modification should be promoted for the obese to reduce their body weight and thereby possibly reduce the risk of future obesity-related renal complications.
format Online
Article
Text
id pubmed-9221229
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-92212292022-06-24 Evaluation of microalbuminuria in obesity phenotypes Alagh, Arzoo R. Shukla, Samarth Acharya, Sourya Vagha, Sunita Dhingra, Loveleen J Family Community Med Original Article BACKGROUND: Obesity is a universal health issue of the present time. Nearly 2 billion people were estimated to be either overweight or obese in 2020, with nearly 3.4 million deaths worldwide. Proteinuria is now widely known to be a significant predictor of renal pathologies including end-stage renal disease. This study aimed to assess the relationship between the presence of microalbuminuria (MA) in obese individuals. MATERIALS AND METHODS: This cross-sectional study was conducted among patients attending the outpatient department of Jawaharlal Nehru Medical College and Acharya Vinoba Bhave Rural Hospital, Sawangi (Meghe), Wardha. From the subjects meeting the study criteria, selected 150 individuals with BMI ≥ 25 that formed the obese group. Obese individuals were further subdivided as metabolic healthy obese (MHO) and metabolic abnormal obese (MAO) based on metablic syndrome criteria. From the non-obese patients (BMI≤25), one age and gender matched control was selected for each obese subject. All subjects were tested for MA by dipstick method. Data was analyzed using SPSS and Chi-square test was performed to test for statistical significance. RESULTS: The study reflected the association of MA in the groups studied. The metabolic abnormal obese group was noted as having the highest percentage of positive cases (53.7%) of MA, followed by the MHO group (31.3%). A significant association of prevalence of MA was seen in MHO and MAO obese individuals (P < 0.001). MA was present in the urine samples of 26 (31.3%) obese subjects in the MHO group, 36 (53.7%) in the MAO group, and 8 (5.3%) in the control population. CONCLUSION: Both MHO and MAO subgroups of obese individuals showed higher proportion of MA indicating adverse renal function. Therefore, primary prophylactic measures such as health education and lifestyle modification should be promoted for the obese to reduce their body weight and thereby possibly reduce the risk of future obesity-related renal complications. Wolters Kluwer - Medknow 2022 2022-05-13 /pmc/articles/PMC9221229/ /pubmed/35754751 http://dx.doi.org/10.4103/jfcm.jfcm_57_22 Text en Copyright: © 2022 Journal of Family and Community Medicine https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Alagh, Arzoo R.
Shukla, Samarth
Acharya, Sourya
Vagha, Sunita
Dhingra, Loveleen
Evaluation of microalbuminuria in obesity phenotypes
title Evaluation of microalbuminuria in obesity phenotypes
title_full Evaluation of microalbuminuria in obesity phenotypes
title_fullStr Evaluation of microalbuminuria in obesity phenotypes
title_full_unstemmed Evaluation of microalbuminuria in obesity phenotypes
title_short Evaluation of microalbuminuria in obesity phenotypes
title_sort evaluation of microalbuminuria in obesity phenotypes
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221229/
https://www.ncbi.nlm.nih.gov/pubmed/35754751
http://dx.doi.org/10.4103/jfcm.jfcm_57_22
work_keys_str_mv AT alagharzoor evaluationofmicroalbuminuriainobesityphenotypes
AT shuklasamarth evaluationofmicroalbuminuriainobesityphenotypes
AT acharyasourya evaluationofmicroalbuminuriainobesityphenotypes
AT vaghasunita evaluationofmicroalbuminuriainobesityphenotypes
AT dhingraloveleen evaluationofmicroalbuminuriainobesityphenotypes